Bonraybio Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	306.31	222.88	159.64	106.27	56.3
Revenue Growth (YoY)	37.43%	39.61%	50.22%	88.78%	111.72%
Cost of Revenue	67.79	47.92	39.85	25.68	16.72
Gross Profit	238.52	174.96	119.79	80.59	39.58
Selling, General & Admin	83.74	72.24	57.34	47.72	34.24
Research & Development	54.83	41.76	41.12	39.51	43.84
Operating Expenses	138.57	114.01	98.45	87.23	78.08
Operating Income	99.95	60.95	21.34	-6.64	-38.5
Interest Expense	-0.13	-0.18	-0.22	-0.15	-0.21
Interest & Investment Income	6.88	3.95	3.01	1.46	0.58
Currency Exchange Gain (Loss)	-2.24	3.54	0.16	5.8	-0.68
Other Non Operating Income (Expenses)	0.32	0.12	0.96	1.25	7.54
EBT Excluding Unusual Items	104.78	68.39	25.25	1.71	-31.27
Gain (Loss) on Sale of Assets	-	-	-	-	-0.42
Other Unusual Items	-	-	0.5	-	-
Pretax Income	104.78	68.39	25.75	1.71	-31.69
Income Tax Expense	2.27	0.03	0.03	0.02	0.02
Net Income	102.51	68.37	25.73	1.69	-31.71
Net Income to Common	102.51	68.37	25.73	1.69	-31.71
Net Income Growth	49.94%	165.75%	1423.09%	-	-
Shares Outstanding (Basic)	25	23	23	20	16
Shares Outstanding (Diluted)	25	23	23	20	16
Shares Change (YoY)	9.08%	0.79%	11.10%	27.99%	16.91%
EPS (Basic)	4.13	3.00	1.14	0.08	-1.99
EPS (Diluted)	4.12	3.00	1.14	0.08	-1.99
EPS Growth	37.33%	163.51%	1272.53%	-	-
Free Cash Flow	81.42	77.96	21.26	7.9	-28.05
Free Cash Flow Per Share	3.27	3.42	0.94	0.39	-1.76
Dividend Per Share	1.500	1.500	0.151	-	-
Dividend Growth	-	892.06%	-	-	-
Gross Margin	77.87%	78.50%	75.04%	75.83%	70.30%
Operating Margin	32.63%	27.35%	13.37%	-6.25%	-68.39%
Profit Margin	33.47%	30.67%	16.11%	1.59%	-56.34%
Free Cash Flow Margin	26.58%	34.98%	13.32%	7.43%	-49.83%
EBITDA	108.95	68.84	28.72	-0.06	-30.15
EBITDA Margin	35.57%	30.89%	17.99%	-0.06%	-53.56%
D&A For EBITDA	9	7.88	7.38	6.57	8.35
EBIT	99.95	60.95	21.34	-6.64	-38.5
EBIT Margin	32.63%	27.35%	13.37%	-6.25%	-68.39%
Effective Tax Rate	2.17%	0.04%	0.10%	1.40%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.